Krystal Biotech Inc (KRYS)
Fixed asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 55,764 | 498 | — | — | — |
Property, plant and equipment | US$ in thousands | 161,202 | 161,684 | 112,355 | 30,876 | 8,475 |
Fixed asset turnover | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $55,764K ÷ $161,202K
= 0.35
The fixed asset turnover ratio for Krystal Biotech Inc has shown a significant improvement from 0.00 in the previous years to 0.35 in 2023. This suggests that the company has become more efficient in generating sales revenue from its investment in fixed assets. A higher fixed asset turnover ratio indicates that the company is utilizing its fixed assets more effectively to generate revenue. It could be a positive sign of improved operational efficiency and better utilization of resources within the organization. Further analysis and monitoring of this ratio trend over time can help in evaluating the company's operational performance and asset management strategies.
Peer comparison
Dec 31, 2023